United StatesFederal vector-borne disease programs are reauthorized through 2030
The law reauthorizes federal work on disease strategy, regional centers, and health department support for 2026 through 2030.
What it does
Federal programs for a national disease strategy, regional centers, and support for health departments are reauthorized for 2026 through 2030.
Federal officials will consult people they consider appropriate when developing the national strategy. The law no longer specifically names the Tick-Borne Disease Working Group.
The regional-centers provision now directs the responsible federal official to act through the named party, instead of working in coordination with it.
Argument forKeeping these programs authorized through 2030 could help federal and local health officials continue work against diseases spread by ticks and other carriers.
Argument againstReplacing a specifically named working group with unspecified appropriate people may make that group’s formal role in the national strategy less certain.
More detail
Congress reauthorizes the covered federal programs for 2026 through 2030. This covers the national strategy, regional centers, and federal support that helps health departments address diseases spread by ticks and other carriers. The reauthorization covers 2026 through 2030, including both years.
Federal officials will consult people they consider appropriate when developing the national strategy. This applies to consultation for the national strategy on diseases spread by ticks and other carriers.
The regional-centers provision directs the responsible federal official to act through the same party rather than coordinate with it. This applies to the regional centers provision in section 317U(c) of the Public Health Service Act.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- Sep 30Signed by President.Became Law
- Sep 30Became Public Law No: 119-118.Minor
- Sep 29Presented to President.To President
- Sep 15Mr. Guthrie moved to suspend the rules and pass the bill.
- Sep 15Considered under suspension of the rules. (consideration: CR H5670-5671)
- Sep 15DEBATE - The House proceeded with forty minutes of debate on S. 2398.
- Sep 15Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H5670)Passed House
- Sep 15Motion to reconsider laid on the table Agreed to without objection.
- Aug 10Message on Senate action sent to the House.
- Aug 10Received in the House.
- Aug 10Held at the desk.
- Aug 6Passed/agreed to in Senate: Passed Senate with an amendment by Voice Vote. (consideration: CR S4494-4495; text: CR S4494-4495)Passed Senate
- 2025
- Sep 8Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report.
- Sep 8Placed on Senate Legislative Calendar under General Orders. Calendar No. 154.
- Jul 30Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
- Jul 23Introduced in Senate
- Jul 23Read twice and referred to the Committee on Health, Education, Labor, and Pensions.Introduced
HealthcareConsumer ProtectionGovernment & Ethics